tom arkell cannabis researcher drive change photo

As the number of registered medical cannabis patients in Australia continues to grow, there is a pressing need to look critically at the current approach to cannabis and driving.

There is a very good body of evidence showing that levels of THC in the body do not correspond well to a person’s level of impairment, the amount of cannabis consumed or the time when it was consumed. This raises serious concerns around the suitability of the current random drug testing approach for patients who are using prescribed medical cannabis.

Tom Arkell

Postdoctoral Researcher: Lambert Initiative For Cannabinoid
Recent posts

Drive Change Update on NSW Drug Driving Laws

Statement by Cate Faehrmann MLC “On Wednesday 19 March 2025, I secured the support of the NSW Legislative Council calling on NSW Police, NSW Health and other relevant government agencies to release all data relating to mobile drug testing and medicinal cannabis. There is currently a distinct lack of available data and information to assess […]

Read more

Reform for Roadside Drug Testing in NSW

This report provides an overview of recent data provided to the Legislative Council by the Minister for Police and Counter-terrorism in New South Wales on 10 September 2024, with regards to roadside drug tests conducted over the last 5 years (by Local Area Command), number of positives by drug type and whether there has been […]

Read more